User profiles for A. Ni

Ai Ni

- Verified email at mskcc.org - Cited by 10595

Aiguo Ni

- Verified email at med.unc.edu - Cited by 3684

Anna Ya Ni

- Verified email at csusb.edu - Cited by 1955

Paracrine mechanisms in adult stem cell signaling and therapy

M Gnecchi, Z Zhang, A Ni, VJ Dzau - Circulation research, 2008 - Am Heart Assoc
Animal and preliminary human studies of adult cell therapy following acute myocardial
infarction have shown an overall improvement of cardiac function. Myocardial and vascular …

[HTML][HTML] Current concepts on osteonecrosis of the femoral head

…, AL Gianakos, JC Villa, A Ni… - World journal of …, 2015 - ncbi.nlm.nih.gov
It is estimated that 20000 to 30000 new patients are diagnosed with osteonecrosis annually
accounting for approximately 10% of the 250000 total hip arthroplasties done annually in the …

[HTML][HTML] Enterococcal disease, epidemiology, and implications for treatment

AH NI, MM Huycke - 2014 - europepmc.org
During the past few decades, enterococci have emerged as important healthcare-associated
pathogens (Arias & Murray, 2012; Austin, Bonten, Weinstein, Slaughter, & Anderson, 1999; …

Numerical simulations of nonstationary fronts and interfaces by the Godunov method in moving grids

VE Fortov, B Goel, CD Munz, AL Ni… - Nuclear science and …, 1996 - Taylor & Francis
A Godunov scheme is proposed for the simulation of impact problems and detonations where
nonstationary fronts and interfaces are tracked as boundaries of subregions that move in …

Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome

…, Y Fan, W Wu, F Zhang, J Wang, A Ni - Clinical infectious …, 2003 - academic.oup.com
In a cohort of 38 patients with severe acute respiratory syndrome (SARS), we observed
leukopenia in 47% of patients, lymphopenia in 84%, and T lymphopenia in 95%. CD4 + T …

[HTML][HTML] Molecular determinants of response to anti–programmed cell death (PD)-1 and anti–programmed death-ligand 1 (PD-L1) blockade in patients with non–small …

…, KA Schalper, JF Gainor, R Shen, A Ni… - Journal of clinical …, 2018 - ncbi.nlm.nih.gov
Purpose Treatment of advanced non–small-cell lung cancer with immune checkpoint inhibitors
(ICIs) is characterized by durable responses and improved survival in a subset of patients…

[PDF][PDF] Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer

…, H Rizvi, BC Creelan, F Sanchez-Vega, A Ahuja, A Ni… - Cancer cell, 2018 - cell.com
Combination immune checkpoint blockade has demonstrated promising benefit in lung
cancer, but predictors of response to combination therapy are unknown. Using whole-exome …

Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non-small-cell lung cancer

…, N Long, H Rizvi, E Auclin, A Ni… - Journal of Clinical …, 2018 - cris.maastrichtuniversity.nl
PurposeTreatment with programmed cell death-1 or programmed death ligand 1 (PD-(L) 1)
inhibitors is now standard therapy for patients with lung cancer. The immunosuppressive …

[HTML][HTML] Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer

JC Osorio, A Ni, JE Chaft, R Pollina, MK Kasler… - Annals of …, 2017 - Elsevier
Background Programmed cell death protein-1 (PD-1) blockade therapies have demonstrated
durable responses and prolonged survival in a variety of malignancies. Treatment is …

Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin …

KL Chan, K Teo, JG Dumesnil, A Ni, J Tam - Circulation, 2010 - Am Heart Assoc
Background— Aortic stenosis (AS) is an active process with similarities to atherosclerosis.
The objective of this study was to assess the effect of cholesterol lowering with rosuvastatin on …